TIDMNSCI

NetScientific PLC

02 October 2017

NetScientific plc

("NetScientific" or the "Company" or the "Group")

Wanda Awarded US Patent which Extends Protection across the US

London, UK - October 2(nd) 2017 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces the issue by the U.S. Patent and Trademark Office of a new patent exclusively licensed to its portfolio company, Wanda. The patent will significantly extend protection for the core technology used in Wanda's software application for remote health and patient management. The patent, titled, "Context-aware prediction in medical systems" is among the technologies developed at UCLA which aim to better assess and predict medical events by defining and using contextual data on top of medical information.

Commenting on the news, NetScientific's Chief Executive Officer and Chairman of Wanda, Francois R. Martelet said: "We are delighted to announce this strengthening of the IP landscape for Wanda, which represents an important step for Wanda's organisational development. We believe Wanda's class leading predictive and behavioural analytics platform acts as a competitive differentiator in the emerging and highly exciting Digital Health sector."

NetScientific holds a 61% stake on a fully diluted basis in Wanda.

For more information, please contact:

 
  NetScientific                                   Tel: +44 (0)20 3514 1800 
   François R. Martelet, 
   M.D., CEO 
   Ian Postlethwaite, CFO 
  Consilium Strategic Communications 
   Mary-Jane Elliott Jessica Hodgson              Tel: +44 (0)20 3709 5700 
   /                                     netscientific@consilium-comms.com 
   Chris Welsh / Laura Thornton 
  Stifel Nicolaus Europe Limited                 Tel: +44 (0) 20 7710 7600 
   (NOMAD and Broker) 
   Jonathan Senior / David Arch 
   / Ben Maddison

About NetScientific

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

About Wanda

San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAMBBTTMBIMTIR

(END) Dow Jones Newswires

October 02, 2017 02:00 ET (06:00 GMT)

Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Netscientific.
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Netscientific.